Sterility Concerns Prompt Warning Letter for Nuclear Medicine Firm

Drug GMP Report
A A
An FDA warning letter is pushing a nuclear medicine company to step up its sterility compliance efforts following a poor inspection.

To View This Article:

Login

Subscribe To Drug GMP Report